Brief: Perceptive Advisors Reports 5.4% Stake In Rhythm Pharmaceuticals- SEC Filing
20/03/2024 21:56
March 21 (Reuters) - Rhythm Pharmaceuticals Inc
RYTM.O :
* PERCEPTIVE ADVISORS LLC REPORTS 5.4% STAKE IN RHYTHM
PHARMACEUTICALS AS OF MARCH 13- SEC FILING
Source text for Eikon: ID:n0001193125-24-072901
Further company coverage: RYTM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Pharmaceuticals
See all newsBrief: Rhythm Pharmaceuticals Announces Appointment Of Manher (Aj) Joshi As Chief Medical Officer
Rhythm's drug shows promise for brain tumor-related weight condition in small study (updated)
Rhythm Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
Rhythm Pharmaceuticals Q2 net loss narrows on US launch demand